Back to Search
JOSEPH HINES, M.D.
M.D.
Family Medicine Physician
NPI: 1427343201IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hospice and Palliative Medicine (Family Medicine) Physician
Family Medicine — Hospice and Palliative Medicine
Code: 207QH0002X
MD449157(PA)
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
MD449157(PA)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
OTHER
Class of 2011
Research & Publications (20)
Metacognitive influences on study time allocation in an associative recognition task: An analysis of adult age differences.
PMID 19485662·Psychol Aging·2009
4-observational
Proteasome inhibition by fellutamide B induces nerve growth factor synthesis.
PMID 18482702·Chem Biol·2008
8-other
Structure of discontinuities in kinetoplast DNA-associated minicircles during S phase in Crithidia fasciculata.
PMID 18039707·Nucleic Acids Res·2008
7-preclinical
Structures of activated fructose-1,6-bisphosphatase from Escherichia coli. Coordinate regulation of bacterial metabolism and the conservation of the R-state.
PMID 17314096·J Biol Chem·2007
7-preclinical
Structures of mammalian and bacterial fructose-1,6-bisphosphatase reveal the basis for synergism in AMP/fructose 2,6-bisphosphate inhibition.
PMID 17933867·J Biol Chem·2007
7-preclinical
Structure of inhibited fructose-1,6-bisphosphatase from Escherichia coli: distinct allosteric inhibition sites for AMP and glucose 6-phosphate and the characterization of a gluconeogenic switch.
PMID 17567577·J Biol Chem·2007
8-other
Nutrient subsidies to belowground microbes impact aboveground food web interactions.
PMID 16869430·Ecology·2006
7-preclinical
Myriaporone 3/4 structure--activity relationship studies define a pharmacophore targeting eukaryotic protein synthesis.
PMID 16880957·Mol Biosyst·2006
7-preclinical
Novel allosteric activation site in Escherichia coli fructose-1,6-bisphosphatase.
PMID 16670087·J Biol Chem·2006
8-other
SPE dose prediction using locally weighted regression.
PMID 16604634·Radiat Prot Dosimetry·2005
8-other
SPE dose prediction using locally weighted regression.
PMID 16604613·Radiat Prot Dosimetry·2005
8-other
Structural determinants for the activation mechanism of the angiotensin II type 1 receptor differ for phosphoinositide hydrolysis and mitogen-activated protein kinase pathways.
PMID 12826267·Biochem Pharmacol·2003
7-preclinical
Identification of angiotensin II type 2 (AT2) receptor domains mediating high-affinity CGP 42112A binding and receptor activation.
PMID 11454929·J Pharmacol Exp Ther·2001
7-preclinical
RNA primer removal and gap filling on a model minicircle replication intermediate.
PMID 11377740·Mol Biochem Parasitol·2001
7-preclinical
Chimeric AT1/AT2 receptors reveal functional similarities despite key amino acid dissimilarities in the domains mediating agonist-dependent activation.
PMID 11551225·Biochemistry·2001
4-observational
Structure-function analysis of Yersinia pestis YopM's interaction with alpha-thrombin to rule on its significance in systemic plague and to model YopM's mechanism of binding host proteins.
PMID 11312613·Microb Pathog·2001
8-other
Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus.
PMID 19605472·J Virol·2009
8-other
Total synthesis and structure-activity investigation of the marine natural product neopeltolide.
PMID 19663512·J Am Chem Soc·2009
7-preclinical
Reply to Lisanby et al. Post hoc analysis does not establish effectiveness of rTMS for depression.
PMID 19528946·Neuropsychopharmacology·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 501 HOWARD AVE, SUITE F2
ALTOONA, PA 16601 - Phone
- (814) 889-2701
Quick Facts
- NPI
- 1427343201
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 15
- Publications
- 20
Are you this provider?
Claim Your Profile